Nurix therapeutics announces participation in the 20th annual needham virtual healthcare conference

San francisco, april 07, 2021 (globe newswire) -- nurix therapeutics, inc. (nasdaq: nrix), a biopharmaceutical company developing targeted protein modulation drugs, today announced that arthur t. sands, m.d., ph.d., nurix's chief executive officer, will participate in a fireside chat at the 20th annual needham virtual healthcare conference on wednesday, april 14th, 2021 at 11:45 a.m. et.
NRIX Ratings Summary
NRIX Quant Ranking